Clinical utility of next-generation sequencing in the diagnosis of hereditary haemolytic anaemias

Archana M. Agarwal, Roberto H. Nussenzveig, Noel S. Reading, Jay L. Patel, Nikhil Sangle, Mohamed Salama, Josef T. Prchal, Sherrie L. Perkins, Hassan M. Yaish, Robert D. Christensen

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Hereditary haemolytic anaemias are genetically and phenotypically heterogeneous disorders characterized by increased red cell destruction, with consequences ranging from innocuous to severe life-threatening anaemia. Diagnostic laboratories endeavour to assist clinicians reach the exact patient diagnosis by using tests principally based on morphological and biochemical techniques. However, these routine studies may be inconclusive, particularly in newborn infants and when transfusions have recently been administered. Large numbers and size of the potentially involved genes also impose a practical challenge for molecular diagnosis using routine sequencing approaches. To overcome these diagnostic shortcomings, we have utilized next-generation sequencing to provide a high-throughput, highly sensitive assay. We developed a panel interrogating 28 genes encoding cytoskeletal proteins and enzymes with sequencing coverage of the coding regions, splice site junctions, deep intronic and regulatory regions. We then evaluated 19 samples, including infants with unexplained extreme hyperbilirubinaemia and patients with transfusion-dependent haemolytic anaemia. Where possible, inheritance patterns of pathogenic mutations were determined by sequencing of immediate relatives. We conclude that this next-generation sequencing panel could be a cost-effective approach to molecular diagnosis of hereditary haemolytic anaemia, especially when the family history is uninformative or when routine laboratory testing fails to identify the causative haemolytic process.

Original languageEnglish (US)
Pages (from-to)806-814
Number of pages9
JournalBritish journal of haematology
Volume174
Issue number5
DOIs
StatePublished - Sep 1 2016
Externally publishedYes

Fingerprint

Congenital Hemolytic Anemia
Inheritance Patterns
Hyperbilirubinemia
Cytoskeletal Proteins
Nucleic Acid Regulatory Sequences
Hemolytic Anemia
Genes
Anemia
Newborn Infant
Costs and Cost Analysis
Mutation
Enzymes

Keywords

  • haemolytic anaemia
  • hereditary anaemias
  • hereditary spherocytosis
  • next generation sequencing
  • RBC membrane defect

ASJC Scopus subject areas

  • Hematology

Cite this

Agarwal, A. M., Nussenzveig, R. H., Reading, N. S., Patel, J. L., Sangle, N., Salama, M., ... Christensen, R. D. (2016). Clinical utility of next-generation sequencing in the diagnosis of hereditary haemolytic anaemias. British journal of haematology, 174(5), 806-814. https://doi.org/10.1111/bjh.14131

Clinical utility of next-generation sequencing in the diagnosis of hereditary haemolytic anaemias. / Agarwal, Archana M.; Nussenzveig, Roberto H.; Reading, Noel S.; Patel, Jay L.; Sangle, Nikhil; Salama, Mohamed; Prchal, Josef T.; Perkins, Sherrie L.; Yaish, Hassan M.; Christensen, Robert D.

In: British journal of haematology, Vol. 174, No. 5, 01.09.2016, p. 806-814.

Research output: Contribution to journalArticle

Agarwal, AM, Nussenzveig, RH, Reading, NS, Patel, JL, Sangle, N, Salama, M, Prchal, JT, Perkins, SL, Yaish, HM & Christensen, RD 2016, 'Clinical utility of next-generation sequencing in the diagnosis of hereditary haemolytic anaemias', British journal of haematology, vol. 174, no. 5, pp. 806-814. https://doi.org/10.1111/bjh.14131
Agarwal, Archana M. ; Nussenzveig, Roberto H. ; Reading, Noel S. ; Patel, Jay L. ; Sangle, Nikhil ; Salama, Mohamed ; Prchal, Josef T. ; Perkins, Sherrie L. ; Yaish, Hassan M. ; Christensen, Robert D. / Clinical utility of next-generation sequencing in the diagnosis of hereditary haemolytic anaemias. In: British journal of haematology. 2016 ; Vol. 174, No. 5. pp. 806-814.
@article{9d0efa4cc56e495898b03d996c477794,
title = "Clinical utility of next-generation sequencing in the diagnosis of hereditary haemolytic anaemias",
abstract = "Hereditary haemolytic anaemias are genetically and phenotypically heterogeneous disorders characterized by increased red cell destruction, with consequences ranging from innocuous to severe life-threatening anaemia. Diagnostic laboratories endeavour to assist clinicians reach the exact patient diagnosis by using tests principally based on morphological and biochemical techniques. However, these routine studies may be inconclusive, particularly in newborn infants and when transfusions have recently been administered. Large numbers and size of the potentially involved genes also impose a practical challenge for molecular diagnosis using routine sequencing approaches. To overcome these diagnostic shortcomings, we have utilized next-generation sequencing to provide a high-throughput, highly sensitive assay. We developed a panel interrogating 28 genes encoding cytoskeletal proteins and enzymes with sequencing coverage of the coding regions, splice site junctions, deep intronic and regulatory regions. We then evaluated 19 samples, including infants with unexplained extreme hyperbilirubinaemia and patients with transfusion-dependent haemolytic anaemia. Where possible, inheritance patterns of pathogenic mutations were determined by sequencing of immediate relatives. We conclude that this next-generation sequencing panel could be a cost-effective approach to molecular diagnosis of hereditary haemolytic anaemia, especially when the family history is uninformative or when routine laboratory testing fails to identify the causative haemolytic process.",
keywords = "haemolytic anaemia, hereditary anaemias, hereditary spherocytosis, next generation sequencing, RBC membrane defect",
author = "Agarwal, {Archana M.} and Nussenzveig, {Roberto H.} and Reading, {Noel S.} and Patel, {Jay L.} and Nikhil Sangle and Mohamed Salama and Prchal, {Josef T.} and Perkins, {Sherrie L.} and Yaish, {Hassan M.} and Christensen, {Robert D.}",
year = "2016",
month = "9",
day = "1",
doi = "10.1111/bjh.14131",
language = "English (US)",
volume = "174",
pages = "806--814",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "Wiley-Blackwell",
number = "5",

}

TY - JOUR

T1 - Clinical utility of next-generation sequencing in the diagnosis of hereditary haemolytic anaemias

AU - Agarwal, Archana M.

AU - Nussenzveig, Roberto H.

AU - Reading, Noel S.

AU - Patel, Jay L.

AU - Sangle, Nikhil

AU - Salama, Mohamed

AU - Prchal, Josef T.

AU - Perkins, Sherrie L.

AU - Yaish, Hassan M.

AU - Christensen, Robert D.

PY - 2016/9/1

Y1 - 2016/9/1

N2 - Hereditary haemolytic anaemias are genetically and phenotypically heterogeneous disorders characterized by increased red cell destruction, with consequences ranging from innocuous to severe life-threatening anaemia. Diagnostic laboratories endeavour to assist clinicians reach the exact patient diagnosis by using tests principally based on morphological and biochemical techniques. However, these routine studies may be inconclusive, particularly in newborn infants and when transfusions have recently been administered. Large numbers and size of the potentially involved genes also impose a practical challenge for molecular diagnosis using routine sequencing approaches. To overcome these diagnostic shortcomings, we have utilized next-generation sequencing to provide a high-throughput, highly sensitive assay. We developed a panel interrogating 28 genes encoding cytoskeletal proteins and enzymes with sequencing coverage of the coding regions, splice site junctions, deep intronic and regulatory regions. We then evaluated 19 samples, including infants with unexplained extreme hyperbilirubinaemia and patients with transfusion-dependent haemolytic anaemia. Where possible, inheritance patterns of pathogenic mutations were determined by sequencing of immediate relatives. We conclude that this next-generation sequencing panel could be a cost-effective approach to molecular diagnosis of hereditary haemolytic anaemia, especially when the family history is uninformative or when routine laboratory testing fails to identify the causative haemolytic process.

AB - Hereditary haemolytic anaemias are genetically and phenotypically heterogeneous disorders characterized by increased red cell destruction, with consequences ranging from innocuous to severe life-threatening anaemia. Diagnostic laboratories endeavour to assist clinicians reach the exact patient diagnosis by using tests principally based on morphological and biochemical techniques. However, these routine studies may be inconclusive, particularly in newborn infants and when transfusions have recently been administered. Large numbers and size of the potentially involved genes also impose a practical challenge for molecular diagnosis using routine sequencing approaches. To overcome these diagnostic shortcomings, we have utilized next-generation sequencing to provide a high-throughput, highly sensitive assay. We developed a panel interrogating 28 genes encoding cytoskeletal proteins and enzymes with sequencing coverage of the coding regions, splice site junctions, deep intronic and regulatory regions. We then evaluated 19 samples, including infants with unexplained extreme hyperbilirubinaemia and patients with transfusion-dependent haemolytic anaemia. Where possible, inheritance patterns of pathogenic mutations were determined by sequencing of immediate relatives. We conclude that this next-generation sequencing panel could be a cost-effective approach to molecular diagnosis of hereditary haemolytic anaemia, especially when the family history is uninformative or when routine laboratory testing fails to identify the causative haemolytic process.

KW - haemolytic anaemia

KW - hereditary anaemias

KW - hereditary spherocytosis

KW - next generation sequencing

KW - RBC membrane defect

UR - http://www.scopus.com/inward/record.url?scp=84987728175&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84987728175&partnerID=8YFLogxK

U2 - 10.1111/bjh.14131

DO - 10.1111/bjh.14131

M3 - Article

C2 - 27292444

AN - SCOPUS:84987728175

VL - 174

SP - 806

EP - 814

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 5

ER -